Article Information
- Received June 10, 2022
- Revision received August 29, 2022
- Accepted August 30, 2022
- First published November 9, 2022.
- Version of record published November 9, 2022.
Author Information
- Steven F. Grieco1,
- Eero Castrén2,
- Gitte M. Knudsen3,
- Alex C. Kwan4,
- David E. Olson5,6,7,
- Yi Zuo8,
- Todd C. Holmes9,10, and
- Xiangmin Xu1,10
- 1Department of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, California 92697
- 2Neuroscience Center-HiLIFE, University of Helsinki, Helsinki, Finland 00014
- 3Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark 2200
- 4Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York 14853
- 5Department of Chemistry, University of California-Davis, Davis, California 95616
- 6Department of Biochemistry & Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, California 95817
- 7Center for Neuroscience, University of California-Davis, Davis, California 95618
- 8Department of Molecular, Cell and Developmental Biology, University of California-Santa Cruz, Santa Cruz, California 95064
- 9Department of Physiology and Biophysics, School of Medicine, University of California, Irvine, California 92697
- 10Center for Neural Circuit Mapping, University of California-Irvine, Irvine, California 92697
Author contributions
Author contributions: X.X., S.F.G., T.C.H., E.C., G.M.K., D.E.O., A.C.K., and Y.Z. prepared the figures and wrote the manuscript; X.X. designed and oversaw writing of the article.
Disclosures
- Received June 10, 2022.
- Revision received August 29, 2022.
- Accepted August 30, 2022.
This work was supported by US National Institutes of Health Grants DA052769 to X.X., R35 GM127102 to T.C.H., and Grants R01GM128997 and R01DA056365 to D.E.O.; Academy of Finland Grant 347358, the Sigrid Juselius Foundation, and the Jane & Aatos Erkko Foundation to E.C.; Innovation Fund Denmark Grant 4108-00004B and Lundbeck Foundation Grant R279-2018-1145 to G.M.K.; and National Institutes of Health Grants R01MH121848 and R01MH128217, and One Mind-COMPASS Rising Star Award to A.C.K.
D.E.O. is a co-founder and the chief innovation officer of Delix Therapeutics, Inc.; A.C.K. is on the board of scientific advisors for Empyrean Neuroscience and Freedom Biosciences. A.C.K. has consulted for Biohaven Pharmaceuticals. No-cost compounds were provided to A.C.K. for research by Usona Institute. The remaining authors declare no competing financial interests.
- Correspondence should be addressed to Xiangmin Xu at xiangmix{at}hs.uci.edu
Funding
HHS | National Institutes of Health (NIH)
DA052769; GM127102; GM128997; DA056365; MH121848; MH128217Academy of Finland (AKA)
347358Sigrid Juselius Foundation
Jane & Aatos Erkko Foundation
Innovation Fund Denmark
4108-00004BLundbeck Foundation
R279-2018-1145One Mind - COMPASS Rising Star Award
Online Impact
